OCULAR THERAPEUTIX, INC Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Ocular Therapeutix, Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2018 to Q3 2024.
  • Ocular Therapeutix, Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 167M shares, a 110% increase year-over-year.
  • Ocular Therapeutix, Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 79.8M shares, a 3.84% increase from 2022.
  • Ocular Therapeutix, Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 76.9M shares, a 0.63% increase from 2021.
  • Ocular Therapeutix, Inc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 76.4M shares, a 25.7% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 167M +87.6M +110% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 166M +87.8M +112% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 132M +54.6M +70.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 79.8M +2.95M +3.84% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 79.4M +2.4M +3.12% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 78M +1.28M +1.67% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 77.4M +641K +0.84% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 76.9M +482K +0.63% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 77M +424K +0.55% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 76.8M +440K +0.58% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 76.7M +675K +0.89% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 76.4M +15.6M +25.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-11
Q3 2021 76.6M +13.6M +21.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 76.3M +19M +33% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 76.1M +24.2M +46.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 60.8M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 63M +16M +34.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 57.4M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 51.9M +9.65M +22.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q3 2019 46.9M +7.93M +20.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q1 2019 42.3M +7.46M +21.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q3 2018 39M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q1 2018 34.8M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.